ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 1111

$596K Total Retail Price of All Prescriptions

Rank: 150 out of 1111

402 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 9,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 489 408 1 2
FUROSEMIDE 421 390 2 6
HYDROCODONE-ACETAMINOPHEN 383 307 S3 3 1
LEVOTHYROXINE SODIUM 335 278 4 3
SIMVASTATIN 329 281 5 5
OMEPRAZOLE 288 245 6 4
GABAPENTIN 288 248 6 10
CITALOPRAM HBR 268 241 8 14
POLYETHYLENE GLYCOL 3350 255 219 9 45
METFORMIN HCL 253 196 10 8
ATORVASTATIN CALCIUM 249 222 11 15
POTASSIUM CHLORIDE 224 218 12 9
TAMSULOSIN HCL 204 182 13 28
AMLODIPINE BESYLATE 197 162 14 7
METOPROLOL TARTRATE 190 160 15 12
METOPROLOL SUCCINATE 165 136 16 20
CLOPIDOGREL 164 152 17 30
DONEPEZIL HCL 142 142 18 25
WARFARIN SODIUM 137 127 19 19
PREDNISONE 135 111 20 48
MIRTAZAPINE 132 131 21 52
CARVEDILOL 122 112 22 21
LANTUS 116 91 23 46
NAMENDA 110 110 24 31
SERTRALINE HCL 109 94 25 24
FLUTICASONE PROPIONATE 106 93 26 27
SPIRONOLACTONE 105 93 27 83
KLOR-CON M20 103 92 28 79
GLIMEPIRIDE 103 103 28 61
PLAVIX 97 90 30 49
ADVAIR DISKUS 93 67 31 43
ZOLPIDEM TARTRATE 89 79 32 16
TRAZODONE HCL 89 71 32 32
PANTOPRAZOLE SODIUM 88 87 34 50
NOVOLOG 87 73 35 104
SPIRIVA 85 65 36 53
NEXIUM 82 64 37 26
MELOXICAM 81 74 38 18
RISPERIDONE 72 55 39 60
DIGOXIN 67 67 40 47
LOSARTAN POTASSIUM 67 62 40 34
METHYLPREDNISOLONE 67 55 40 93
ALENDRONATE SODIUM 62 47 43 35
PRAVASTATIN SODIUM 60 31 44 17
VENLAFAXINE HCL ER 60 38 44 105
HYDROCHLOROTHIAZIDE 59 46 46 11
TRAMADOL HCL 58 45 47 13
OXYCODONE-ACETAMINOPHEN 55 44 S2 48 147
CYMBALTA 54 39 49 40
ESCITALOPRAM OXALATE 54 53 49 78
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 51 23
ONGLYZA 52 33 52 316
JANUVIA 51 51 53 75
PROAIR HFA 51 35 53 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 38 55 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.